ASX Share rice
Sat 15 Aug 2020 - 05:34:pm (Sydney)

TDL Share Price

TBG DIAGNOSTICS LIMITEDTDLPharmaceuticals, Biotechnology & Life Sciences

TDL Company Information

Name:

TBG Diagnostics Limited

Sector:

Healthcare

Industry:

Diagnostics & Research

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

138 Juliette Street Greenslopes QLD Australia 4120

Phone:

61 7 3088 7926

Exec. Chairman:

Mr. Indrajit Solomon Arulampalam

Chief Financial Officer:

Ms. Generosa Hipona

Company Sec.:

Mr. Justyn Peter Stedwell

Chief Operating Officer:

Mr. Willy M. Hsu

Chief Scientific Officer:

Dr. Michael Chen

Company Overview:

TBG Diagnostics Limited, a molecular diagnostics company, develops, manufactures, and markets molecular diagnostics kits, instruments, and services in Taiwan and China. It provides ExProbe HLA and HPA kits for human leukocyte antigen (HLA) and human platelet antigens (HPA) allele genotyping, which uses real time polymerase chain reaction (PCR) techniques with sequence specific primers and probes; Morgan SSP HLA kits for determining HLA alleles using PCR techniques with sequence specific primers; HLAssure SBT HLA Kits for transplantation donor selection; and AccuType SBT analysis software to analyze sequences from all ab1 based files. The company also offers Morgan SSPal HLA Typing Analysis Software, a gel result interpretation software; HLA typing services that offer low to high resolution using PCR fragment analysis (SSP) and DNA sequencing (SBT); QPCR Q6000, a six-channel real time PCR instrument; QzNGS NGS that provides high resolution HLA genotyping; and COVID-19 testing kits. It serves clinical labs, blood centers, and bone marrow registry labs. The company was formerly known as Progen Pharmaceuticals Limited and changed its name to TBG Diagnostics Limited in December 2015. TBG Diagnostics Limited was incorporated in 1989 is based in Greenslopes, Australia.

TDL Share Price Information

Shares Issued:

217.59M

Market Capitalisation:

$58.75M

Revenue (TTM):

$3.35M

Revenue Per Share (TTM):

$0.02

Earnings per Share:

$0.003

Profit Margin:

0.2286

Operating Margin (TTM):

$-1.20

Return On Assets (TTM):

$-0.18

Return On Equity (TTM):

$-0.91

Quarterly Revenue Growth (YOY):

0.212

Gross Profit(TTM):

$2.52M

Diluted Earnings Per Share (TTM):

$0.003

TDL CashFlow Statement

CashFlow Date:

2019-12-31

Investments:

$-729,875

Change To Liabilities:

$1.09M

Total Cashflow From Investing Activities:

$-729,875

Net Borrowings:

$767.55K

Net Income:

$764.94K

Total Cash From Operating Activities:

$-2,323,704

Depreciation:

$736.47K

Other Cashflow From Investing Activities:

$1.67M

Capital Expenditures:

$271.16K

TDL Income Statement

Income Date:

2019-12-31

Income Before Tax:

$-11,221,989

Net Income:

$764.94K

Gross Profit:

$2.52M

Operating Income:

$-4,008,084

Total Revenue:

$3.35M

Total Operating Expenses:

$4.67M

Cost Of Revenue:

$822.62K

TDL Balance Sheet

Balance Sheet Date:

2019-12-31

Total Liabilities:

$2.18M

Total Stockholder Equity:

$12.86M

Other Current Liabilities:

$49.92K

Total Assets:

$15.04M

Common Stock:

$36.21M

Other Current Assets:

$187.70K

Retained Earnings:

$-27,619,094

Other Assets:

$206.33K

Cash:

$5.21M

Total Current Liabilities:

$2.18M

Short-Term Debt:

$0.95M

Property - Plant & Equipment:

$1.28M

Net Tangible Assets:

$12.86M

Long-Term Investments:

$7.14M

Total Current Assets:

$6.41M

Net Receivables:

$1.64M

Short-Term Investments:

$8.63M

Inventory:

$848.18K

Accounts Payable:

$172.04K

Non Currrent Assets (Other):

$8.44M

Short-Term Investments:

$8.63

Non Current Liabilities Total:

$0

TDL Share Price History

TDL News

18 Oct, 2019
It's not possible to invest over long periods without making some bad investments. But really big losses can really...